CLINUVEL: developing innovative treatments for stroke patients

CLINUVEL’s Head of Clinical Operations, Dr Pilar Bilbao, provides an overview of results from the first clinical study of CLINUVEL’s drug afamelanotide in arterial ischaemic stroke (AIS) patients, then discusses the impact for patients’ lives and gives an update on the next steps in the clinical program for AIS.

Read more about CLINUVEL developing a treatment for acute ischaemic stroke

Related Articles

Get in Touch


Latest Posts